Zobrazeno 1 - 10
of 111
pro vyhledávání: '"William Makis"'
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2476-2478 (2024)
Externí odkaz:
https://doaj.org/article/b0b841fddbd64cb0b99b1fa9b60ace6a
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2479-2480 (2024)
Externí odkaz:
https://doaj.org/article/1768b5a13e6345078c171fdad2e84f3a
Publikováno v:
Vaccines, Vol 11, Iss 5, p 991 (2023)
Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel vaccine platform based on mRNA technology was introduced to the market. Globally, around 13.38 billion COVID-19 vaccine doses of diverse platforms have been administer
Externí odkaz:
https://doaj.org/article/f0aabfe54827474aa54272c37495244c
Autor:
Nicolas Hulscher, BS, Paul E. Alexander, PhD, Richard Amerling, MD, Heather Gessling, MD, Roger Hodkinson, MD, William Makis, MD, Harvey A. Risch, MD, PhD, Mark Trozzi, MD, Peter A. McCullough, MD, MPH
Background: The rapid development and widespread deployment of COVID-19 vaccines, combined with a high number of adverse event reports, have led to concerns over possible mechanisms of injury including systemic lipid nanoparticle (LNP) and mRNA distr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07caec9dc650b284ff1faf9614fb06cd
Due to the health crisis caused by SARS-CoV-2, the creation of a new vaccine platform based on mRNA was implemented. Globally, around 13.32 billion COVID-19 vaccine doses of diverse platforms have been given, and up to this date, 69.7% of the total p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6fbdf2c570b957b0a3e49d089e1d11d
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 27, Iss 2, Pp 91-95 (2018)
A 60-year-old female with no significant medical history presented with hematuria. A computed tomography (CT) scan revealed extensive lymphadenopathy with hypodensities in the liver and spleen, and she was referred for an 18F-fluorodeoxyglucose (18F-
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 27, Iss 1, Pp 37-40 (2018)
A 65-year-old male patient with a one year history of liver transplantation was referred for an 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) to rule out post transplant lymphoproliferative disease.
Autor:
Emmanuel W. Hudson, William Makis
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 27, Iss 1, Pp 32-36 (2018)
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy
A 49-year-old male patient with a prior history of poor compliance with medical appointments was referred for an 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for the staging of a rectal squamous cel
Autor:
William Makis, Anthony Ciarallo
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 26, Iss 3, Pp 93-100 (2017)
Objective The purpose of the current study is to examine the incidence and clinical significance of unexpected focal uptake of 18F-fluorodeoxyglucose (18F-FDG) on positron emission tomography/computed tomography (PET/CT) in the thyroid gland of oncol
Autor:
William Makis, Anthony Ciarallo
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 26, Iss 2, Pp 76-82 (2017)
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy
The aim of this study was to evaluate the clinical significance of incidental focal uptake ofA retrospective review of 3122 consecutive male patients who underwentIncidentalAmaç: Bu çalışmanın amacı kanser hastalarının prostat bezinde pozitro